Nimbus Therapeutics competitorsClear all

Nimbus Therapeutics's top competitors include Codiak Biosciences, Aligos Therapeutics and AstraZeneca.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Nimbus Therapeutics
Nimbus Therapeutics
Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases.
Codiak Biosciences
Codiak Biosciences
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Aligos Therapeutics
Aligos Therapeutics
Aligos Therapeutics is a company that develops curative therapies for hepatologic diseases and viral infections.
AstraZeneca
AstraZeneca
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Founding Date
Founding Date
2009
Founding Date
2015
Founding Date
2018
Founding Date
1999
Type
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Locations
South San Francisco, US HQ
Leuven, BE
Locations
Cambridge, GB HQ
Alger, DZ
Buenos Aires, AR
Haedo, AR
Macquarie Park, AU
Macquarie Park, AU
North Ryde, AU
see more
Employees
Employees
678% increase
Employees
101
Employees
8628% increase
Employees
76,1008% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
328.6 m
Valuation ($)
714.1 m
Valuation ($)
166 b
Twitter followers
Twitter followers
1.2 k
Twitter followers
193
Twitter followers
157
Twitter followers
295.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
77
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
8.5
Average likes per tweet (last 30 days)
2.7
Average likes per tweet (last 30 days)
0.5
Average likes per tweet (last 30 days)
27.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
93.51%
Alexa Website Rank
Alexa Website Rank
294954
Alexa Website Rank
N/A
Alexa Website Rank
236419
Alexa Website Rank
59119
Employee Rating
Employee Rating
4.5
Employee Rating
4.2
Employee Rating
N/A
Employee Rating
4.2

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$2.9m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$24.4b (FY, 2019)
Net income
Net income
N/A
Net income
($91.7m) (FY, 2020)
Net income
($108.5m) (FY, 2020)
Net income
$1.2b (FY, 2019)

Operating

Pre-Clinical Phase Products
Pre-Clinical Phase Products
N/A
Pre-Clinical Phase Products
2 (Q2, 2020)
Pre-Clinical Phase Products
4 (Q2, 2020)
Pre-Clinical Phase Products
N/A

Funding

Total funding raised
Total funding raised
$ 242m
Total funding raised
$ 168.5m
Total funding raised
$ 225m
Total funding raised
$ 1b
For sources of this data, please see the company profile

View company profiles

Codiak Biosciences
HQ
Cambridge, US
Employees
101

Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.

View company
Aligos Therapeutics
HQ
South San Francisco, US
Employees
86↑ 28% increase

Aligos Therapeutics is a company that develops curative therapies for hepatologic diseases and viral infections.

View company
AstraZeneca
HQ
Cambridge, GB
Employees
76,100↑ 8% increase

AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.

View company